Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

Robin L. Washington

Executive VP and Chief Financial Officer
Small Molecules
Gilead
United States of America

Robin L. Washington

Biography

Ms. Washington joined Gilead in 2008 as Senior Vice President and Chief Financial Officer where she oversees the Global Finance and Information Technology organizations. Ms. Washington was promoted to Executive Vice President in 2014.  Ms. Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Prior to that, Ms. Washington served in a number of executive positions with PeopleSoft, most recently in the role of Senior Vice President and Corporate Controller. Ms. Washington previously served on the Board of Directors of Tektronix, Inc. (acquired by Danaher), the Board of Directors of MIPS Technologies Inc. (acquired by Imagination), and currently is a member of the Board of Directors of Honeywell International, the Board of Directors of Salesforce.com, and the Board of Visitors, Graziadio School of Business and Management, Pepperdine University. Ms. Washington is a certified public accountant and holds a bachelor's degree in business administration from the University of Michigan and a MBA from Pepperdine University.

Research Interest

Research-based biopharmaceutical company

Global Experts from United States of America

Global Experts in Subject

Share This Profile